LYRM03
LYRM03 is a ubenimex-derived aminopeptidase inhibitor that attenuates LPS-induced acute lung injury in mice. It functions by suppressing pro-inflammatory mediator expression and inhibiting MyD88-dependent TLR4 signaling in alveolar macrophages, highlighting its potential for sepsis-related lung injury research.
Product Specifications
CAS Number
1820750-36-4
Smiles
[C@H] (C (N[C@@H] ([C@H] (CC) C) C (O) =O) =O) (NC ([C@H] ([C@@H] (CC1=CC=CC=C1) N) O) =O) C (C) C
Molecular Formula
C21H33N3O5
Molecular Weight
407.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7068131 Inquire
Recombinant Escherichia coli O7:K1 Membrane protein insertase YidC (yidC), partial
Sign In for Pricing
View Details 
PA2060-carrier-free 100 µg/Vial
Anti-Factor VII/F7 Antibody Picoband®, Carrier-free
Sign In for Pricing
View Details 
438934-01 1 mg
6,6’-Methylenebis[ (3RS) -9-methyl-3-[ (2-methyl-1H-imidazol-1-yl) methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one-d6 (Ondansetron Impurity B)
Sign In for Pricing
View Details